Nexgel (NXGL) Current Deferred Revenue (2020 - 2025)
Historic Current Deferred Revenue for Nexgel (NXGL) over the last 5 years, with Q3 2025 value amounting to $180000.0.
- Nexgel's Current Deferred Revenue rose 55.87% to $180000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $180000.0, marking a year-over-year increase of 55.87%. This contributed to the annual value of $179000.0 for FY2024, which is 79500.0% up from last year.
- Per Nexgel's latest filing, its Current Deferred Revenue stood at $180000.0 for Q3 2025, which was up 55.87% from $180000.0 recorded in Q2 2025.
- In the past 5 years, Nexgel's Current Deferred Revenue registered a high of $286000.0 during Q1 2025, and its lowest value of $20000.0 during Q4 2023.
- Moreover, its 4-year median value for Current Deferred Revenue was $179000.0 (2024), whereas its average is $152500.0.
- In the last 5 years, Nexgel's Current Deferred Revenue skyrocketed by 79500.0% in 2024 and then skyrocketed by 55.87% in 2025.
- Over the past 4 years, Nexgel's Current Deferred Revenue (Quarter) stood at $38000.0 in 2021, then crashed by 47.37% to $20000.0 in 2023, then surged by 795.0% to $179000.0 in 2024, then increased by 0.56% to $180000.0 in 2025.
- Its last three reported values are $180000.0 in Q3 2025, $180000.0 for Q2 2025, and $286000.0 during Q1 2025.